This document discusses best practices for using LC-MS/MS to quantify drug metabolizing enzymes and transporters in order to predict inter-individual variability. It describes selecting unique surrogate peptides, qualifying peptides, optimizing sample preparation and LC-MS/MS analysis to minimize technical variability. A case example shows the age-dependent expression of ADH1A, ADH1B, ADH1C and ALDH1A1 increasing 10-fold from neonatal to adulthood when quantified in human liver cytosol samples. The document concludes by acknowledging collaborators who provided funding, samples and technical support.